aldose reductase inhibitors (University of Colorado)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Namealdose reductase inhibitors (University of Colorado)
Drug Alias Namebeta-glucogallin
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic cataractDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic cataractDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A